Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-008929
Filing Date
2023-03-21
Accepted
2023-03-21 16:03:07
Documents
5
Effectiveness Date
2023-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 s-8-asfiled.htm S-8 122973
2 EX-5.1 cue-ex5_1.htm EX-5 25839
3 EX-23.2 cue-ex23_2.htm EX-23 5441
4 EX-FILING FEES cue-exfiling_fees.htm EX-FILING FEES 52427
5 GRAPHIC img152828397_0.jpg GRAPHIC 2329
  Complete submission text file 0000950170-23-008929.txt   211084
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270718 | Film No.: 23749727
SIC: 2834 Pharmaceutical Preparations